Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II

Molecular and Cellular Endocrinology

Volumn 378, Issue 1-2, 2013, Pages 53-58

  Nistala, Ravi ^a,b   Whaley Connell, Adam ^a,c  

^a University of Missouri   (United States)

^b Dialysis Clinics Inc   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiorenal metabolic syndrome; Chronic kidney disease; Glomerulus; Hyperinsulinemia; Insulin resistance; Obesity

Indexed keywords

ANGIOTENSIN II; MAMMALIAN TARGET OF RAPAMYCIN; MEGALIN; PROTEIN SERINE THREONINE KINASE; SODIUM CHLORIDE;

ARTICLE; CARDIORENAL SYNDROME; CHRONIC KIDNEY DISEASE; ENZYME ACTIVATION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MICROALBUMINURIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; PROTEINURIA; SIGNAL TRANSDUCTION;

CARDIORENAL METABOLIC SYNDROME; CHRONIC KIDNEY DISEASE; GLOMERULUS; HYPERINSULINEMIA; INSULIN RESISTANCE; OBESITY;

ALBUMINURIA; ANGIOTENSIN II; ANIMALS; CARDIO-RENAL SYNDROME; HUMANS; INSULIN RESISTANCE; KIDNEY GLOMERULUS; METABOLIC SYNDROME X; SIGNAL TRANSDUCTION;

EID: 84884411740     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.02.005     Document Type: Article

References (77)

1. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15(7):539-553.
2. Anderson P.W., Zhang X.Y., Tian J., Correale J.D., Xi X.P., Yang D., Graf K., Law R.E., Hsueh W.A. Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. Kidney Int. 1996, 50(3):745-753.
3. Bhandari B.K., Feliers D., Duraisamy S., Stewart J.L., Gingras A.C., Abboud H.E., Choudhury G.G., Sonenberg N., Kasinath B.S. Insulin regulation of protein translation repressor 4E-BP1, an eIF4E-binding protein, in renal epithelial cells. Kidney Int. 2001, 59(3):866-875.
4. Bonnet F., Cooper M.E., Kawachi H., Allen T.J., Boner G., Cao Z. Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 2001, 44:874-877.
5. Catena C., Cavarape A., Novello M., Giacchetti G., Sechi L.A. Insulin receptors and renal sodium handling in hypertensive fructose-fed rats. Kidney Int. 2003, 64:2163-2171.
6. Chasman D.I., et al. Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function. Hum. Mol. Genet. 2012, 21(24):5329-5343.
7. Chen J., Muntner P., Hamm L.L., Fonseca V., Batuman V., Whelton P.K., He J. Insulin resistance and risk of chronic kidney disease in non diabetic US adults. J. Am. Soc. Nephrol. 2003, 14:469-477.
8. Chen S., Jim B., Ziyadeh F.N. Diabetic nephropathy and transforming growth beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin. Nephrol. 2003, 23:532-543.
9. Chen J., Muntner P., Hamm L.L., Jones D.W., Batuman V., Fonseca V., Whelton P.K., He J. The metabolic syndrome and chronic kidney disease in US adults. Ann. Intern. Med. 2004, 140(3):167-174.
10. Chen J., Muntner P., Hamm L.L., Jones D.W., Batuman V., Fonseca V., Whelton P.K., He J. The metabolic syndrome and chronic kidney disease in US adults. Ann. Int. Med. 2004, 140:167-174.
11. Chen J.K., Chen J., Thomas G., Kozma S.C., Harris R.C. S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am. J. Physiol. Renal. Physiol. 2009, 297(3):F585-F593.
12. Chiu T., Santiskulvong C., Rozengurt E. GF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288(2):G182-G194.
13. Conti F.G., Striker L.J., Lesniak M.A., MacKay K., Roth J., Striker G.E. Studies on binding and mitogenic effect of insulin and insulin-like growth factor I in glomerular mesangial cells. Endocrinology 1988, 122(6):2788-2795.
14. Coward R.J., Welsh G.I., Yang J., Tasman C., Lennon R., Koziell A., Satchell S., Holman G.D., Kerjaschki D., Tavaré J.M., Mathieson P.W., Saleem M.A. The Human Glomerular Podocyte Is A Novel Target For Insulin Action. Diabetes 2005, 54(11):3095-3102.
15. DeFronzo R.A., Cooke C.R., Andres R., Faloona G.R., Davis P.J. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J. Clin. Invest. 1975, 55:845-855.
16. Durvasula R.V., Petermann A.T., Hiromura K., Blonski M., Pippin J., Mundel P., Pichler R., Griffin S., Couser W.G., Shankland S.J. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int. 2004, 65:30-39.
17. Ejerblad E., Fored C.M., Lindblad P., Fryzek J., McLaughlin J.K., Nyrén O. Obesity and risk for chronic renal failure. J. Am. Soc. Nephrol. 2006, 17:1695-1702.
18. Emoto M., Nishizawa Y., Maekawa K., Kawagishi T., Kogawa K., Hiura Y., Mori K., Tanaka S., Ishimura E., Inaba M., Okuno Y., Morii H. Insulin resistance in non-obese, non-insulin-dependent diabetic patients with diabetic nephropathy. Metabolism 1997, 46(9):1013-1018.
19. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004, 291(7):844-850.
20. Gekle M. Renal tubule albumin transport. Annu. Rev. Physiol. 2005, 67:573-594.
21. Gelber R., Kurth T., Kausz A.T., Manson J.E., Buring J.E., Levey A.S., Gaziano J.M. Association between body mass index and CKD in apparently healthy men. Am. J. Kidney Dis. 2005, 46:871-880.
22. + exchange activity in proximal tubules from normotensive and hypertensive rats. Am. J. Physiol. 1991, 260:F695-F703.
23. Gloy J., Henger A., Fischer K.G., Nitschke R., Mundel P., Bleich M., Schollmeyer P., Greger R., Pavenstädt H. Angiotensin II depolarizes podocytes in the intact glomerulus of the rat. J. Clin. Invest. 1997, 99:2772-2781.
24. Godel M., Hartleben B., Herbach N., Liu S., Zschiedrich S., Lu S., Debreczeni-Mór A., Lindenmeyer M.T., Rastaldi M.P., Hartleben G., Wiech T., Fornoni A., Nelson R.G., Kretzler M., Wanke R., Pavenstädt H., Kerjaschki D., Cohen C.D., Hall M.N., Rüegg M.A., Inoki K., Walz G., Huber T.B. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J. Clin. Invest. 2011, 121(6):2197-2209.
25. Gonzalez-Villalobos R., Klassen R.B., Allen P.L., Johanson K., Baker C.B., Kobori H., Navar L.G., Hammond T.G. Megalin binds and internalizes angiotensin-(1-7). Am. J. Physiol. Renal. Physiol. 2006, 290(5):F1270-F1275.
26. Gotthardt M., Trommsdorff M., Nevitt M.F., Shelton J., Richardson J.A., Stockinger W., Nimpf J., Herz J. Interactions of the low density lipoprotein receptor gene family with cytosolic adaptor and scaffold proteins suggest diverse biological functions in cellular communication and signal transduction. J. Biol. Chem. 2000, 275(33):25616-25624.
27. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr. Opin. Cardiol. 2006, 21(1):1-6.
28. Gual P., Le Marchand-Brustel Y. Tanti JF positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005 Jan, 87(1):99-109.
29. Habibi J., Hayden M.R., Sowers J.R., Pulakat L., Tilmon R.D., Manrique C., Lastra G., Demarco V.G., Whaley-Connell A. Nebivolol attenuates redox-sensitive glomerular and tubular mediated proteinuria in obese rats. Endocrinology 2010, 152(2):659-668.
30. Hafizi S., Wang X., Chester A.H., Yacoub M.H., Proud C.G. Ang II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2004, 287(3):H1232-H1238.
31. Han S.Y., Kang Y.S., Jee Y.H., Han K.H., Cha D.R., Kang S.W., Han D.S. High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes. Cell Tissue Res. 2005, 28:1-12.
32. Hayden M.R., Whaley-Connell A., Sowers J.R. Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte. Am. J. Nephrol. 2005, 25(6):553-569.
33. Hitomi H., Mehta P.K., Taniyama Y., Lassègue B., Seidel-Rogol B., San Martin A., Griendling K.K. Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK. Am. J. Physiol. Cell Physiol. 2011, 301(6):C1415-C1422.
34. Hosojima M., Sato H., Yamamoto K., Kaseda R., Soma T., Kobayashi A., Suzuki A., Kabasawa H., Takeyama A., Ikuyama K., Iino N., Nishiyama A., Thekkumkara T.J., Takeda T., Suzuki Y., Gejyo F., Saito A. Regulation of megalin expression in cultured proximal tubule cells by angiotensin II type 1A receptor- and insulin-mediated signaling cross talk. Endocrinology 2009, 150(2):871-878.
35. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., Go A.S. Body mass index and risk for end-stage renal disease. Ann. Int. Med. 2006, 144(1):21-28.
36. Inoki K., Mori H., Wang J., Suzuki T., Hong S., Yoshida S., Blattner S.M., Ikenoue T., Rüegg M.A., Hall M.N., Kwiatkowski D.J., Rastaldi M.P., Huber T.B., Kretzler M., Holzman L.B., Wiggins R.C., Guan K.L. MTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J. Clin. Invest. 2011, 121(6):2181-2196.
37. Iseki K., Ikemiya Y., Kinjo K., Inoue T., Iseki C., Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int. 2004, 65(5):1870-1876.
38. Ketsawatsomkron P., Stepp D.W., Fulton D.J., Marrero M.B. Molecular mechanism of angiotensin II-induced insulin resistance in aortic vascular smooth muscle cells: roles of protein tyrosine phosphatase-1B. Vascul. Pharmacol. 2010, 53(3-4):160-168.
39. Kobayashi S., Maesato K., Moriya H., Ohtake T., Ikeda T. Insulin resistance in patients with chronic kidney disease. Am. J. Kidney Dis. 2005, 45(2):275-280.
40. Leheste J.R., Rolinski B., Vorum H., Hilpert J., Nykjaer A., Jacobsen C., Aucouturier P., Moskaug J.O., Otto A., Christensen E.I., Willnow T.E. Megalin knockout mice as an animal model of low molecular weight proteinuria. Am. J. Pathol. 1999, 155(4):1361-1370.
41. Li Y., Cong R., Biemesderfer D. The COOH terminus of megalin regulates gene expression in opossum kidney proximal tubule cells. Am. J. Physiol. Cell Physiol. 2008, 295(2):C529-C537.
42. Li L., Garikepati R.M., Tsukerman S., Tiwari S., Ecelbarger C.M. Salt sensitivity of nitric oxide generation and blood pressure in mice with targeted knockout of the insulin receptor from the renal tubule. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2012, 303(5):R505-R512.
43. Lieberthal W., Levine J.S. The role of the mammalian target of rapamycin (mTOR) in renal disease. J. Am. Soc. Nephrol. 2009, 20(12):2493-2502.
44. Manhiani M.M., Duggan A.D., Wilson H., Brands M.W. Chronic intrarenal insulin replacement reverses diabetes mellitus-induced natriuresis and diuresis. Hypertension 2012, 59(2):421-430.
45. Marmy-Conus N., Hannan K.M., Pearson R.B. Ro 31-6045, the inactive analogue of the protein kinase C inhibitor Ro 31-8220, blocks in vivo activation of p70(s6k)/p85(s6k): implications for the analysis of S6K signalling. FEBS Lett. 2002, 519(1-3):135-140.
46. Mifsud S.A., Allen T.J., Bertram J.F., Hulthen U.L., Kelly D.J., Cooper M.E., Wilkinson-Berka J.L., Gilbert R.E. Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade. Diabetologia 2003, 2001(44):878-882.
47. Mima A., Ohshiro Y., Kitada M., Matsumoto M., Geraldes P., Li C., Li Q., White G.S., Cahill C., Rask-Madsen C., King G.L. Glomerular-specific protein kinase C-ß-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesity. Kidney Int. 2011, 79:883-896.
48. Morrisey K., Evans R.A., Wakefield L., Phillips A.O. Translational regulation of renal proximal tubular epithelial cell transforming growth factor-beta1 generation by insulin. Am. J. Pathol. 2001, 159(5):1905-1915.
49. Mykkanen L., Zaccaro D.J., Wagenknecht L.E., Robbins D.C., Gabriel M., Haffner S.M. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998, 47(1):793B800.
50. Nakagawa T., Sato W., Glushakova O., Heinig M., Clarke T., Campbell-Thompson M., Yuzawa Y., Atkinson M.A., Johnson R.J., Croker B. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J. Am. Soc. Nephrol. 2007, 18(2):539-550.
51. Nakamura R., Emmanouel D.S., Katz A.I. Insulin binding sites in various segments of the rabbit nephron. J. Clin. Invest. 1983, 72:388-392.
52. Nicholas S.B. Advances in pathogenetic mechanisms of diabetic nephropathy. Cell. Mol. Biol. 2003, 49(8):1319-1325.
53. Nistala R., Sowers J.R., Whaley-Connell A. Over-nutrition contributes to tubulointerstitial fibrosis by targeting nutrient-sensing kinases: role for the mTOR/S6K pathway. Cell Cycle 2012, 11(5):831-832.
54. Ogasawara S., Hosojima M., Kaseda R., Kabasawa H., Yamamoto-Kabasawa K., Kurosawa H., Sato H., Iino N., Takeda T., Suzuki Y., Narita I., Yamagata K., Tomino Y., Gejyo F., Hirayama Y., Sekine S., Saito A. Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes. Diabetes Care 2012, 35(5):1112-1118.
55. Pavenstadt H., Kriz W., Kretzler M. Cell biology of the glomerular podocyte. Physiol. Rev. 2003, 83:253-307.
56. Pulakat L., DeMarco V.G., Whaley-Connell A., Sowers J.R. The impact of over-nutrition on insulin metabolic signaling in the heart and kidney. Cardiorenal. Med. 2011, 1:102-112.
57. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. 2002. Circulation vol. 106, no. 25, pp. 3143-3421.
58. Russo L.M., Sandoval R.M., Campos S.B., Molitoris B.A., Comper W.D., Brown D. Impaired tubular uptake explains albuminuria in early diabetic nephropathy. J. Am. Soc. Nephrol. 2009, 20(3):489-494.
59. Saab G., Whaley-Connell A., McFarlane S.I., Li S., Chen S.C., Sowers J.R., Bakris G.L., McCullough P.A. The association of parathyroid hormone levels and the cardiorenal metabolic syndrome in non-diabetic chronic kidney disease. Cardiorenal. Med. 2001, 1:123-130.
60. Shepard P.R., Kahn B.B. Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N. Eng. J. Med. 1999, 341:248-257.
61. Sherajee S.J., Fujita Y., Rafiq K., Nakano D., Mori H., Masaki T., Hara T., Kohno M., Nishiyama A., Hitomi H. Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor. Arterioscler. Thromb. Vasc. Biol. 2012, 32(2):257-263.
62. Sowers J.R. Insulin resistance and hypertension. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H1597-H1602.
63. Stenvinkel P., Bolinder J., Alvestrand A. Effects of insulin on renal haemodynamics and the proximal and distal tubular sodium handling in healthy subjects. Diabetologia 1992, 35:1042-1048.
64. Thrailkill K.M., Nimmo T., Bunn R.C., Cockrell G.E., Moreau C.S., Mackintosh S., Edmondson R.D., Fowlkes J.L. Microalbuminuria in type 1 diabetes is associated with enhanced excretion of the endocytic multiligand receptors megalin and cubilin. Diabetes Care 2009, 32(7):1266-1268.
65. Tiwari S., Riazi S., Ecelbarger C.A. Insulin's impact on renal sodium transport and blood pressure in health, obesity, and diabetes. Am. J. Physiol. Renal. Physiol. 2007, 293(4):F974-F984.
66. Tiwari S., Sharma N., Gill P.S., Igarashi P., Kahn C.R., Wade J.B., Ecelbarger C.M. Impaired sodium excretion and increased blood pressure in mice with targeted deletion of renal epithelial insulin receptor. Proc. Natl. Acad. Sci. USA 2008, 105(17):6469-6474.
67. US Renal Data System: USRDS. 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesada, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
68. Wei Y., Whaley-Connell A.T., Chen K., Habibi J., Uptegrove G.M., Clark S.E., Stump C.S., Ferrario C.M., Sowers J.R. NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. Hypertension 2007, 50:384-391.
69. Welsh G.I., Hale L.J., Eremina V., Jeansson M., Maezawa Y., Lennon R., Pons D.A., Owen R.J., Satchell S.C., Miles M.J., Caunt C.J., McArdle C.A., Pavenstädt H., Tavaré J.M., Herzenberg A.M., Kahn C.R., Mathieson P.W., Quaggin S.E., Saleem M.A., Coward R.J. Insulin signaling to the glomerular podocyte is critical for normal kidney function. Cell Metab. 2010, 12(4):329-340.
70. Whaley-Connell A.T., Chowdhury N.A., Hayden M.R., Stump C.S., Habibi J., Wiedmeyer C.E., Gallagher P.E., Tallant E.A., Cooper S.A., Link C.D., Ferrario C., Sowers J.R. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. Am. J. Physiol. Renal. Physiol. 2006, 291(6):F1308-F1314.
71. Whaley-Connell A., Pavey B.S., McCullough P.A., Saab G., Li S., McFarlane S.I., Chen S.C., Vassalotti J.A., Collins A.J., Bakris G., Sowers J.R. Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program. J. Clin. Hypertens. (Greenwich) 2010, 12(1):51-58. KEEP Investigators.
72. Whaley-Connell A., Habibi J., Panfili Z., Hayden M.R., Schneider R., Bagree S., Nistala R., Parrish A., Sowers J.R. Angiotensin II activation of mTOR/S6K contributes to loss of N-cadherin and tubulointerstitial fibrosis. Am. J. Nephrol. 2011, 34(2):115-125. [29].
73. Whaley-Connell A., Habibi J., Panfili Z., Hayden M.R., Bagree S., Nistala R., Hyder S., Krueger B., Demarco V., Pulakat L., Ferrario C.M., Parrish A., Sowers J.R. Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin. Am. J. Nephrol. 2011, 34(2):115-125.
74. Whaley-Connell A.T., Habibi J., Nistala R., Demarco V.G., Pulakat L., Hayden M.R., Joginpally T., Ferrario C.M., Parrish A.R., Sowers J.R. Mineralocorticoid receptor-dependent proximal tubule injury is mediated by a redox-sensitive mTOR/S6K1 pathway. Am. J. Nephrol. 2012, 35(1):90-100.
75. Yamagata K., Ishida K., Sairenchi T., Takahashi H., Ohba S., Shiigai T., Narita M., Koyama A. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007, 71:159-166.
76. Yamakawa T., Tanaka S., Kamei J., Kadonosono K., Okuda K. Phosphatidylinositol 3-kinase in angiotensin II-induced hypertrophy of vascular smooth muscle cells. Eur. J. Pharmacol. 2003, 478(1):39-46.
77. Zou Z., Chung B., Nguyen T., Mentone S., Thomson B., Biemesderfer D. Linking receptor-mediated endocytosis and cell signaling: evidence for regulated intramembrane proteolysis of megalin in proximal tubule. J. Biol. Chem. 2004, 279(33):34302-34310.